BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31301662)

  • 21. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
    Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
    J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
    Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
    Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
    Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.
    Wakahashi S; Sudo T; Oka N; Ueno S; Yamaguchi S; Fujiwara K; Ohbayashi C; Nishimura R
    Transl Res; 2013 Sep; 162(3):181-90. PubMed ID: 23856093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
    Ye F; Hu Y; Zhou C; Hu Y; Chen H
    Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.
    Miše BP; Telesmanić VD; Tomić S; Šundov D; Čapkun V; Vrdoljak E
    Pathol Oncol Res; 2015 Apr; 21(2):347-56. PubMed ID: 25108408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.
    Tanaka Y; Terai Y; Kawaguchi H; Fujiwara S; Yoo S; Tsunetoh S; Takai M; Kanemura M; Tanabe A; Ohmichi M
    Cancer Biol Ther; 2013 Jan; 14(1):13-9. PubMed ID: 23114646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
    Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
    Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer.
    Yamada S; Fuchs BC; Fujii T; Shimoyama Y; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y; Nakao A
    Surgery; 2013 Nov; 154(5):946-54. PubMed ID: 24075276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?
    Cheng JC; Auersperg N; Leung PC
    PLoS One; 2012; 7(3):e34071. PubMed ID: 22479527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
    Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS
    Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.
    Hänze J; Henrici M; Hegele A; Hofmann R; Olbert PJ
    BMC Cancer; 2013 Dec; 13():589. PubMed ID: 24325461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
    Law AY; Wong CK
    Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
    Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C
    Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.
    Gallo D; Ferlini C; Scambia G
    Curr Drug Targets; 2010 Apr; 11(4):474-81. PubMed ID: 20015012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of tumor satellite variables in reflecting the epithelial-mesenchymal transition of tongue cancer.
    Yang TL; Wu CT; Ko JY; Wang CP; Lou PJ; Chang YL
    Oral Oncol; 2011 Aug; 47(8):720-4. PubMed ID: 21664858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.